Literature DB >> 28005183

Altered Gray Matter Volume in Stable Chronic Obstructive Pulmonary Disease with Subclinical Cognitive Impairment: an Exploratory Study.

Chunrong Wang1,2, Yanhui Ding3, Bixian Shen2, Dehong Gao2, Jie An4, Kewen Peng2, Gangqiang Hou2, Liqiu Zou2, Mei Jiang2, Shijun Qiu5,6.   

Abstract

Gray matter volume deficits have been identified in cognitively impaired patients with chronic obstructive pulmonary disease (COPD). However, it remains unknown whether the gray matter volume is altered in COPD patients with subclinical cognitive impairment. To determine whether any gray matter abnormalities are present in these patients, neuropsychological tests and structural MRI data were analyzed from 60 patients with COPD and 60 age-, gender-, education-, and handedness-matched normal controls (NCs). The COPD patients had similar Mini-Mental State Examination (MMSE) scores compared with the NCs. However, they had reduced Montreal Cognitive Assessment (MoCA) scores for visuospatial and executive and naming and memory functions (P < 0.001). Voxel-based morphometry (VBM) analysis revealed that the COPD patients had significantly lowered gray matter volumes in several brain regions, including the left precuneus (PrCU), bilateral calcarine (CAL), right superior temporal gyrus/middle temporal gyrus (STG/MTG), bilateral fusiform gyrus (FG), and right inferior parietal lobule (IPL) (P < 0.01, corrected). Importantly, the forced vital capacity (FVC) was found to be associated with the gray matter volume in the calcarine. The present study confirmed that brain structural changes were present in stable COPD patients with subclinical cognitive impairment. These findings may provide new insights into the pathogenesis of COPD.

Entities:  

Keywords:  Brain; Chronic obstructive pulmonary disease (COPD); Cognitive impairment; Gray matter volume; Hypoxia; Voxel-based morphometry (VBM)

Mesh:

Year:  2016        PMID: 28005183     DOI: 10.1007/s12640-016-9690-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  78 in total

1.  Effect of fMRI acoustic noise on non-auditory working memory task: comparison between continuous and pulsed sound emitting EPI.

Authors:  Sven Haller; Andreas J Bartsch; Ernst W Radue; Markus Klarhöfer; Erich Seifritz; Klaus Scheffler
Journal:  MAGMA       Date:  2005-11-18       Impact factor: 2.310

2.  Effects of smoking marijuana on brain perfusion and cognition.

Authors:  Daniel S O'Leary; Robert I Block; Julie A Koeppel; Michael Flaum; Susan K Schultz; Nancy C Andreasen; Laura Boles Ponto; G Leonard Watkins; Richard R Hurtig; Richard D Hichwa
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

3.  Changes in brain morphology in patients with obstructive sleep apnoea.

Authors:  M J Morrell; M L Jackson; G L Twigg; R Ghiassi; D W McRobbie; R A Quest; H Pardoe; G S Pell; D F Abbott; P D Rochford; G D Jackson; R J Pierce; F J O'Donoghue; D R Corfield
Journal:  Thorax       Date:  2010-10       Impact factor: 9.139

4.  Increased serum levels of HSP27 as a marker for incipient chronic obstructive pulmonary disease in young smokers.

Authors:  Hendrik Jan Ankersmit; Stefanie Nickl; Eva Hoeltl; Michael Toepker; Christopher Lambers; Andreas Mitterbauer; Benedikt Kortuem; Matthias Zimmermann; Bernhard Moser; Christine Bekos; Barbara Steinlechner; Helmut Hofbauer; Walter Klepetko; Peter Schenk; Balazs Dome
Journal:  Respiration       Date:  2012       Impact factor: 3.580

Review 5.  New insights into the immunology of chronic obstructive pulmonary disease.

Authors:  Guy G Brusselle; Guy F Joos; Ken R Bracke
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

Review 6.  Toward a consensus definition for COPD exacerbations.

Authors:  R Rodriguez-Roisin
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images.

Authors:  Kazunari Ishii; Takashi Kawachi; Hiroki Sasaki; Atsushi K Kono; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 8.  The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?

Authors:  Jørgen Vestbo; Suzanne S Hurd; Roberto Rodriguez-Roisin
Journal:  Clin Respir J       Date:  2012-10       Impact factor: 2.570

9.  Decreased functional connectivity of the amygdala in Alzheimer's disease revealed by resting-state fMRI.

Authors:  Hongxiang Yao; Yong Liu; Bo Zhou; Zengqiang Zhang; Ningyu An; Pan Wang; Luning Wang; Xi Zhang; Tianzi Jiang
Journal:  Eur J Radiol       Date:  2013-05-03       Impact factor: 3.528

10.  Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease.

Authors:  Yong Liu; Chunshui Yu; Xinqing Zhang; Jieqiong Liu; Yunyun Duan; Aaron F Alexander-Bloch; Bing Liu; Tianzi Jiang; Ed Bullmore
Journal:  Cereb Cortex       Date:  2013-01-11       Impact factor: 5.357

View more
  11 in total

1.  Abnormal intrinsic functional hubs and connectivity in stable patients with COPD: a resting-state MRI study.

Authors:  Haijun Li; Huizhen Xin; Jingjing Yu; Honghui Yu; Juan Zhang; Wenjing Wang; Dechang Peng
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

2.  Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study.

Authors:  Siyi Li; Peilin Lv; Min He; Wenjing Zhang; Jieke Liu; Yao Gong; Ting Wang; Qiyong Gong; Yulin Ji; Su Lui
Journal:  Front Med       Date:  2020-04-08       Impact factor: 4.592

3.  White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.

Authors:  Catherine A Spilling; Paul W Jones; James W Dodd; Thomas R Barrick
Journal:  BMC Pulm Med       Date:  2017-06-19       Impact factor: 3.317

4.  Altered amplitude of low-frequency fluctuation in basal ganglia correlates to pulmonary ventilation function in COPD patients: A resting-state fMRI study.

Authors:  Chun-Qiang Lu; Weiwei Xu; Chu-Hui Zeng; Lu-Yao Ge; Yuan-Cheng Wang; Xiang-Pan Meng; Qian Yu; Di Wu; Shenghong Ju
Journal:  Brain Behav       Date:  2019-05-29       Impact factor: 2.708

5.  Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function.

Authors:  Catherine A Spilling; Mohani-Preet K Bajaj; Daniel R Burrage; Sachelle Ruickbie; N Jade Thai; Emma H Baker; Paul W Jones; Thomas R Barrick; James W Dodd
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-21

6.  Disrupted resting-state spontaneous neural activity in stable COPD.

Authors:  Huizhen Xin; Haijun Li; Honghui Yu; Jingjing Yu; Juan Zhang; Wenjing Wang; Dechang Peng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-27

7.  Effect of 12-week pulmonary rehabilitation on cognitive function in patients with stable chronic obstructive pulmonary disease: study protocol for a single-center randomised controlled trial.

Authors:  Hongxia Duan; Peijun Li; Zhenwei Wang; Haixia Chen; Ting Wang; Weibing Wu; Xiaodan Liu
Journal:  BMJ Open       Date:  2020-10-16       Impact factor: 2.692

8.  Changes in Spatial Working Memory in Stable Chronic Obstructive Pulmonary Disease: A Retrospective Study.

Authors:  Zhi Lv; Panpan Hu; Yinglin Jiang; Wanchun Yang; Rui Wang; Kai Wang; Xiaoyun Fan
Journal:  Biomed Res Int       Date:  2020-07-22       Impact factor: 3.411

9.  Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.

Authors:  Tian-Lai Lin; Wei-Wen Chen; Zhi-Rong Ding; Si-Can Wei; Ming-Lian Huang; Cai-Hui Li
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

10.  Disruption of white matter connectivity in chronic obstructive pulmonary disease.

Authors:  Catherine A Spilling; Paul W Jones; James W Dodd; Thomas R Barrick
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.